Neurotoxicity after treatment with muromonab-CD3.
Richards
J M
JM
Vogelzang
N J
NJ
Bluestone
J A
JA
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003221:Confusion / Q000209:etiology; D006261:Headache / Q000209:etiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016853:Muromonab-CD3; D009422:Nervous System Diseases / Q000209:etiology*
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3